Sign up now
Log In

Investigational treatment for small cell lung cancer

Researchers at UniSC Clinical Trials are testing a new treatment for limited-stage small cell lung cancer (SCLC). This study focuses on a treatment that could boost the immune system to fight tumours by blocking a protein commonly found in cancers, including SCLC.

  • Cancer screening and treatment

Study Purpose/Description

Researchers at UniSC Clinical Trials are testing a new treatment for limited-stage small cell lung cancer (SCLC) at the Sunshine Coast Haematology and Oncology Clinic in Buderim. SCLC makes up about 15–20% of lung cancers, with current treatments including chemotherapy and radiotherapy. Surgery is an option for only a small number of patients.

This study focuses on a treatment that could boost the immune system to fight tumours by blocking a protein commonly found in cancers, including SCLC. Blocking this protein ccould potentially improve outcomes in patients with the disease.

Participation will be of no cost, private health insurance not required.

What’s Involved?

This study is divided into three stages:

  • Screening (up to 28 days)
  • Treatment (21-day cycles)
  • Follow-up (90 days after the last dose for safety, then check-ins every 12 weeks).

Taking part also involves the following procedures:

  • Physical exams
  • Vital signs checked
  • Heart tests (ECG and echocardiography)
  • ECOG scoring
  • Pregnancy tests (if applicable)
  • Blood and urine tests
  • Immunogenicity assessments
  • Completion of questionnaires

The trial will be overseen by Dr Brenton Seidl at Sunshine Coast Haematology and Oncology Clinic on the Sunshine Coast and is sponsored by Shanghai Henlius Biotech.

Find out more:

If you are interested and think you may be eligible, you can learn more and complete a screening survey at the UniSC Clinical Trials study website.  

Recruitment criteria

You may be eligible to participate in this study if you:

  • Aged 18 years or older
  • Have been diagnosed with Stage I to III limited-stage small cell lung cancer
  • Have NOT previously received systematic anti-tumour treatments for SCLC
  • Are willing and able to attend study visits at Sunshine Coast Haematology and Oncology clinic in Buderim, QLD

Benefits

All participants will receive reimbursement for their time on the study.

Study sponsor / funder

Research team contacts

Research Team

[email protected]

Register your interest

Join Us Register

For Participants

For Researchers

Resources

An initiative of

SIGN UP NOW

The Join Us Register Acknowledges the Traditional Owners of the lands across Australia as the continuing custodians of Country and acknowledge the many Aboriginal and Torres Strait Islander people of this land. We pay our respect to First Nations peoples and Elders, past and present.

We acknowledge and celebrate the knowledge and the strengths of Aboriginal and Torres Strait Islander peoples and communities and recognise their continuing connection to land and waters.

We thank the many Aboriginal and Torres Strait Islander communities, and the many individuals, organisations that have supported and guided us through our journey.

There is a huge opportunity to partner more with Aboriginal and Torres Strait Islander communities to build on existing community strengths and resilience, often in the face of ongoing inequities. Through Join Us, we will work together in the spirit of reciprocity to address ongoing impacts of colonisation so that we can all realise optimal health and wellbeing.

Copyright 2024 Join Us register. All rights reserved.

+61 2 8052 4798

[email protected]

Facebook Twitter

The Join Us Register is currently funded by the Australian Stroke and Heart Research Accelerator (ASHRA). 

For more information about ASHRA, click here.

Register your interest


    Please sign up on Join Us here
    You need to be registerd to deterime if you quilify for the study